Production Ready Seeds Phylos focuses on Production-Ready Seed hybrids that deliver high quality, stable genetics for commercial cannabis cultivation, offering a clear entry point for sales teams to position premium seed concepts to growers aiming for reliable yield and cost efficiency.

Strategic Partnerships Recent and ongoing partnerships with ILGM, Organigram, and collaborations related to THCV genetics present opportunities to cross-sell seed lines, genotype testing services, and plant genetics tools to large-scale operators and contract manufacturers seeking validated programs.

Clinical & THCV Focus Phylos’ clinical research initiatives around THCV and appetite/motivation outcomes open doors to co-branded trials, educational content, and specialty ingredient collaborations with beverage, supplement, or wellness brands seeking scientifically supported cannabis-derived ingredients.

Data-Driven Differentiation Galaxy and plant genotype testing platforms provide a differentiator for customers needing precise strain identification, sex testing, and phenotype stability data, enabling upsell of analytics services and seed traits that reduce cultivation risk.

Growth & Scale Potential With revenue in the mid tens of millions, a modest funding base, and a small but distributed team, Phylos is positioned to pursue enterprise customers and regional grower networks, offering scalable seed programs and integration support to accelerate adoption.